• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

    9.920 -0.940 (-8.66%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 93,905
    Open 10.36
    Bid (Size) 9.330 (100)
    Ask (Size) 11.50 (600)
    Prev. Close 10.86
    Today's Range 9.750 - 10.55
    52wk Range 4.880 - 19.58
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -30.7%
    -30.7%
    1 Month
    -28.8%
    -28.8%
    3 Month
    -8.0%
    -8.0%
    6 Month
    +0.3%
    +0.3%
    1 Year
    -30.7%
    -30.7%

    More News

    Read More
    News headline image
    This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗
    Via Benzinga
    News headline image
    Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics to Present at Upcoming Investor Conferences in November
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Coinbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Aardvark Therapeutics Reports Q2 Loss ↗
    Via The Motley Fool
    News headline image
    Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress ↗
    Via Benzinga
    Topics Initial Public Offering
    News headline image
    Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?
    Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?
    The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market
    What is the current price of Aardvark Therapeutics, Inc. - Common Stock?
    The current price of Aardvark Therapeutics, Inc. - Common Stock is 9.920
    When was Aardvark Therapeutics, Inc. - Common Stock last traded?
    The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 11/14/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.